Hacisalihoglu Uguray Payam, Sahin Davut
Department of Pathology, Istanbul Yeni Yuzyil University Faculty of Medicine, Gaziosmanpasa Hospital, Istanbul, Turkey.
Department of Pathology, Acibadem Health Group, Istanbul, Turkey.
Sisli Etfal Hastan Tip Bul. 2021 Mar 17;55(1):68-75. doi: 10.14744/SEMB.2019.86729. eCollection 2021.
Hematopoietic stem cell transplantation by allogeneic bone marrow transplantation is a method used in the treatment of various genetic, immunological disorders, hematologic and solid organ malignancies. Graft versus Host Disease is one of the major and fatal complications of allogeneic bone marrow transplantation. It is a systemic disease affecting five main areas: skin, gastrointestinal tract, liver, lung and hematopoietic system. Diagnosis of cutaneous Graft versus Host Disease is made by the correlation between clinical and histopathological findings of the patient. The present study aims to investigate the incidence of cutaneous graft versus Host Disease in allogeneic bone marrow transplantation patients in our center, to discuss the histopathological features and differential diagnosis of cutaneous graft versus Host Disease in the light of the literature.
The pathology slides of allogeneic bone marrow transplantation patients who were diagnosed as graft versus Host Disease in our pathology department between January 2015 and January 2019 were re-evaluated. Epidermal and dermal histomorphological findings of the disease were classified; the patients' clinical and demographic information was obtained from the files. The incidence of cutaneous Graft versusHost Disease was calculated.
In our center, between January 2015 and January 2019, 273 pediatric and 100 adult patients underwent allogeneic and 181 autologous bone marrow transplantation. Twenty-three patients who underwent allogeneic bone marrow transplantation had cutaneous Graft versus Host Disease whereas and 21 patients had gastrointestinal Graft versus Host Disease. The incidence of cutaneous and gastrointestinal Graft versus Host Disease was 16.1% whereas the incidence of cutaneous Graft versus Host Disease was 8.42%. The most common clinical differential diagnosis of cutaneous Graft versus Host Disease was drug reaction (74%). The most common epidermal histomorphologic finding in our cases was keratinocyte necrosis (87%). In our cases, the most common epidermal histomorphologic finding was keratinocyte necrosis (87%). This was followed by vacuolar degeneration in basal keratinocytes (63%), acanthosis and spongiosis (61%), respectively. The most common finding in the dermis was pigment incontinence (59%). Of the patients with Graft versus Host Disease, 56% had transplantation from unrelated donors, whereas 44% of them had transplantation from their relatives.
Cutaneous Graft versus Host Disease is a common complication of allogeneic hematopoietic stem cell transplantation. It is associated with high mortality rates and has a significant negative impact on the patient's quality of life. Dermatological early recognition of the disease; histopathological evaluation and verification with differential diagnosis plays a key role in preventing patient morbidity and mortality.
异基因骨髓移植进行造血干细胞移植是一种用于治疗各种遗传性、免疫性疾病、血液系统及实体器官恶性肿瘤的方法。移植物抗宿主病(GVHD)是异基因骨髓移植的主要致命并发症之一。它是一种影响五个主要部位的全身性疾病:皮肤、胃肠道、肝脏、肺和造血系统。皮肤GVHD的诊断通过患者的临床和组织病理学表现的相关性来做出。本研究旨在调查我院中心异基因骨髓移植患者中皮肤GVHD的发生率,结合文献探讨皮肤GVHD的组织病理学特征及鉴别诊断。
对2015年1月至2019年1月间在我院病理科被诊断为GVHD的异基因骨髓移植患者的病理切片进行重新评估。对该病的表皮和真皮组织形态学表现进行分类;从病历中获取患者的临床和人口统计学信息。计算皮肤GVHD的发生率。
在我院中心,2015年1月至2019年1月间,273例儿科患者和100例成年患者接受了异基因骨髓移植,181例患者接受了自体骨髓移植。23例接受异基因骨髓移植的患者发生了皮肤GVHD,21例患者发生了胃肠道GVHD。皮肤和胃肠道GVHD的发生率为16.1%,而皮肤GVHD的发生率为8.42%。皮肤GVHD最常见临床鉴别诊断是药物反应(74%)。在我们的病例中,最常见的表皮组织形态学表现是角质形成细胞坏死(87%)。在我们的病例中,最常见的表皮组织形态学表现是角质形成细胞坏死(87%)。其次分别是基底角质形成细胞的空泡变性(63%)、棘层肥厚和海绵形成(61%)。真皮中最常见的表现是色素失禁(59%)。在发生GVHD的患者中,56%接受了无关供体的移植,而44%接受了亲属的移植。
皮肤GVHD是异基因造血干细胞移植的常见并发症。它与高死亡率相关,对患者的生活质量有重大负面影响。皮肤科医生对该病的早期识别;组织病理学评估及鉴别诊断的验证在预防患者发病和死亡方面起关键作用。